Which ETFs own LKFT.AS?
Lakefront Biotherapeutics NV — 6 ETFs hold it, worth $22.5M across 821.49K shares.
Holdings as of Aug 26, 2026 — portfolio reporting dates from the data provider; not live positions.
| # | ETF | Weight | Shares | Value | ETF AUM | Category | Today | |
|---|---|---|---|---|---|---|---|---|
| 1 | FDTS First Trust Developed Markets ex-US… | 0.35% | 1.72K | $48.4K | $14.1M | Developed Markets | +0.31% | |
| 2 | PDN Invesco RAFI Developed Markets ex-U.S.… | 0.07% | 9.53K | $268.1K | $364.6M | Developed Markets | +0.24% | |
| 3 | VSS Vanguard FTSE All-World ex-US Small-Cap… | 0.04% | 197.82K | $5.4M | $13.60B | Developed Markets | +0.65% | |
| 4 | VGK Vanguard FTSE Europe ETF | 0.01% | 119.06K | $3.3M | $38.50B | Developed Markets | -0.45% | |
| 5 | VEA Vanguard FTSE Developed Markets ETF | 0.00% | 483.75K | $13.3M | $315.00B | Developed Markets | -0.09% | |
| 6 | VSGX Vanguard ESG International Stock ETF | 0.00% | 9.60K | $263.2K | $6.50B | Developed Markets | -0.05% |
Coverage reflects the ETF portfolios loaded in our database; very small funds may not be swept yet. Market data delayed approximately 15–20 minutes unless otherwise indicated.